Total synthesis of bryostatin 1.
Keck GE, Poudel YB, Cummins TJ, Rudra A, Covel JA.
J Am Chem Soc · research-article; journal article; research support, n.i.h., extramural · DOI 10.1021/ja110198y PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för bryostatin 1. Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
39 träffarChallenges to the development of bryostatin-type anticancer drugs based on the activation mechanism of protein kinase Cδ.
Irie K, Yanagita RC, Nakagawa Y.
Med Res Rev · research support, non-u.s. gov't; review; journal article · DOI 10.1002/med.20220New approaches to the total synthesis of the bryostatin antitumor macrolides.
Hale KJ, Manaviazar S.
Chem Asian J · review; journal article · DOI 10.1002/asia.200900634Bryostatin-1: pharmacology and therapeutic potential as a CNS drug.
Sun MK, Alkon DL.
CNS Drug Rev · research-article; review; journal article · DOI 10.1111/j.1527-3458.2006.00001.xBryostatin-1: a novel PKC inhibitor in clinical development.
Kortmansky J, Schwartz GK.
Cancer Invest · research support, u.s. gov't, p.h.s.; review; journal article · DOI 10.1081/cnv-120025095The rational design of potential chemotherapeutic agents: synthesis of bryostatin analogues.
Wender PA, Hinkle KW, Koehler MF, Lippa B.
Med Res Rev · research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; review; journal article · DOI 10.1002/(sici)1098-1128(199909)19:5<388::aid-med6>3.0.co;2-hModulation of ara-C induced apoptosis in leukemia by the PKC activator bryostatin 1.
Grant S.
Front Biosci · research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; review; journal article; research support, n.i.h., extramural · DOI 10.2741/a187Bryostatin 1: differentiating agent from the depths.
Stone RM.
Leuk Res · comment; review; journal article · DOI 10.1016/s0145-2126(96)00123-3Differentiation and growth modulation of myeloid leukemia cells by the protein kinase C activating agent bryostatin-1.
Steube KG, Drexler HG.
Leuk Lymphoma · comparative study; review; journal article · DOI 10.3109/10428199309148517